BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2305716)

  • 21. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
    Kohn EC; Steis RG; Sausville EA; Veach SR; Stocker JL; Phelps R; Franco S; Longo DL; Bunn PA; Ihde DC
    J Clin Oncol; 1990 Jan; 8(1):155-60. PubMed ID: 2295906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine in the treatment of cutaneous T cell lymphoma.
    Street ML; Muller SA; Pittelkow MR
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1084-9. PubMed ID: 2273106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides).
    Kessler JF; Jones SE; Levine N; Lynch PJ; Booth AR; Meyskens FL
    Arch Dermatol; 1987 Feb; 123(2):201-4. PubMed ID: 2949706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.
    Cox EB; Vogel CL; Carpenter JT; Raney M
    Invest New Drugs; 1988 Apr; 6(1):37-9. PubMed ID: 3410666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome): Use in a community setting.
    Reddy SA
    Crit Rev Oncol Hematol; 2016 Oct; 106():99-107. PubMed ID: 27637355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of teniposide in patients with ovarian cancer.
    D'Incalci M; Rossi C; Sessa C; Urso R; Zucchetti M; Farina P; Mangioni C
    Cancer Treat Rep; 1985 Jan; 69(1):73-7. PubMed ID: 3967261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teniposide is not effective in chronic lymphocytic leukemia.
    Zagonel V; Tirelli U; Veronesi A; Galligioni E; Tumolo S; Roncadin M; Carbone A; Grigoletto E
    Blut; 1986 Jan; 52(1):59-61. PubMed ID: 3632912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary Syndrome.
    Querfeld C; Zain J; Rosen ST
    Cancer Treat Res; 2019; 176():225-248. PubMed ID: 30596221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
    Tummarello D; Guidi F; Di Furia L; Gramazio A; Menichetti E; Cellerino R
    J Chemother; 1989 Feb; 1(1):64-7. PubMed ID: 2542470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
    Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
    Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P; Fierro MT; Rossotto GL; Savoia P; Bernengo MG
    Br J Dermatol; 2004 Feb; 150(2):327-36. PubMed ID: 14996105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
    Chiuten DF; Bennett JM; Creech RH; Glick J; Falkson G; Brodovsky HS; Begg CB; Muggia FM; Carbone PP
    Cancer Treat Rep; 1979 Jan; 63(1):7-11. PubMed ID: 369693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa.
    Jumbou O; N'Guyen JM; Tessier MH; Legoux B; Dréno B
    Br J Dermatol; 1999 Mar; 140(3):427-31. PubMed ID: 10233261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VM26: phase I and II studies.
    Macbeth FR
    Cancer Chemother Pharmacol; 1982; 7(2-3):87-91. PubMed ID: 7044595
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis and therapy of cutaneous T-cell lymphomas].
    Le T; Pierard GE; Pierard-Franchimont C; de la Brassinne M; Lapière CM
    Dermatologica; 1984; 169(2):60-5. PubMed ID: 6332749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome.
    Child F; Ortiz-Romero PL; Alvarez R; Bagot M; Stadler R; Weichenthal M; Alves R; Quaglino P; Beylot-Barry M; Cowan R; Geskin LJ; Pérez-Ferriols A; Hellemans P; Elsayed Y; Phelps C; Forslund A; Kamida M; Zinzani PL
    Br J Dermatol; 2016 Jul; 175(1):80-8. PubMed ID: 26836950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.